Modeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicine

PURPOSE: Radioiodine therapy (RAI) has traditionally been used as treatment for metastatic thyroid cancer, based on its ability to concentrate iodine. Propositions to maximize tumor response with minimizing toxicity, must recognize the infinite possibilities of empirical tests. Therefore, an approac...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbolosi, Dominique, Summer, Ilyssa, Meille, Christophe, Serre, Raphaël, Kelly, Antony, Zerdoud, Slimane, Bournaud, Claire, Schvartz, Claire, Toubeau, Michel, Toubert, Marie-Elisabeth, Keller, Isabelle, Taïeb, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503603/
https://www.ncbi.nlm.nih.gov/pubmed/28389624
http://dx.doi.org/10.18632/oncotarget.16637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503603/
https://www.ncbi.nlm.nih.gov/pubmed/28389624
http://dx.doi.org/10.18632/oncotarget.16637

Ejemplares similares